Wednesday, December 11, 2013

Mechanism identified that is implicated in brain cancer and a drug that decreases brain tumor growth

Researchers at the University of Calgary's Hotchkiss Brain Institute (HBI) have made a discovery that could lead to better treatment for patients suffering from brain cancer.Despite current treatment strategies, the median survival for patients with the most aggressive brain cancer - called glioblastoma, is 15 months. Less than five per cent of patients survive beyond five years.HBI member V.

No comments:

Post a Comment